Idorsia announces management change
Idorsia Ltd is listed on the SIX Swiss Stock exchange, we provide an archive of our media releases o...
Publisher
Switzerland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Idorsia Ltd is listed on the SIX Swiss Stock exchange, we provide an archive of our media releases o...
Source route
Continue on idorsia.com
Leave the platform to read the original full article on the publisher site.
Source: Idorsia (IR)
Scope: Industry
Related coverage
More related coverage
Results from EMBRACE Phase 2a study of emapalumab in interferon-gamma-driven sepsis presented at ISICEM
Primary endpoint: improvement in organ function observed in 60% of patients receiving high-dose emap...
IDEAYA Biosciences Announces Upcoming Presentations at AACR 2026 Highlighting Multiple Clinical Stage Pipeline Programs
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announ...
Subscribe to Press release email alerts
Sign up for BMY email alerts and receive timely updates on press releases.